FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileiShares US Pharmaceuticals ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
IHE
iShares US Pharmaceuticals ETF ETF AnalysisComprehensive ETF analysis for iShares US Pharmaceuticals ETF (IHE) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisIHE
IHE
iShares US Pharmaceuticals ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
IHE
  1. Home
  2. Screener
  3. iShares US Pharmaceuticals ETFIHEETF
iShares US Pharmaceuticals ETF Logo

iShares US Pharmaceuticals ETF

ETF
🇺🇸IHE•AMEX•Equity

Your view on IHE

iShares US Pharmaceuticals ETF Logo

iShares US Pharmaceuticals ETF

ETFIShares
🇺🇸IHE•AMEX•Equity
AUM (USD)$1.65B
Expense Ratio0.37%
Yield (TTM)1.34%
Holdings52

Sentiment

—

AUM (USD)

$1.65B

Expense Ratio

0.37%

Yield (TTM)

1.34%

Holdings

52

Sentiment

—
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

iShares US Pharmaceuticals ETF (IHE) is an Equity fund from iShares, listed since 2006, with $1.7B in assets under management, a 0.37% expense ratio and a NAV of $106.55 USD.

Overview for iShares US Pharmaceuticals ETF

Fund Type
ETF
Fund Issuer
IShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
May 1, 2006
Domicile
US
Website
ishares.com/us/products/239519/ishares-u-s-pharmaceuticals-etf
Fund Type
ETF
Fund Issuer
IShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
May 1, 2006
Domicile
US
Website
ishares.com/us/products/239519/ishares-u-s-pharmaceuticals-etf
Fund Type
ETF
Fund Issuer
IShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
May 1, 2006
Domicile
US
Website
ishares.com/us/products/239519/ishares-u-s-pharmaceuticals-etf

About this fund

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector.

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Equity

Expense Ratio

0.37%

Yield (TTM)

1.34%

AUM

$1.65B

Fund Details

NAV$106.55 USD
Holdings52
Average Volume270.7K
Inception DateMay 1, 2006
Asset ClassEquity
Fund IssuerIShares
DomicileUS
ISINUS4642888360
CUSIP464288836
NAV CurrencyUSD

Expense Ratio

0.37%

Dividend Yield (TTM)

1.34%

Assets Under Management

$1.65B

NAV

$106.55 USD

Holdings

52

Average Volume

270.7K

Inception Date

May 1, 2006

Asset Class

Equity

Fund Issuer

IShares

Domicile

US

ISIN

US4642888360

CUSIP

464288836

NAV Currency

USD

Expense Ratio

0.37%

Dividend Yield (TTM)

1.34%

Assets Under Management

$1.65B

NAV

$106.55 USD

Holdings

52

Average Volume

270.7K

Inception Date

May 1, 2006

Asset Class

Equity

Fund Issuer

IShares

Domicile

US

ISIN

US4642888360

CUSIP

464288836

NAV Currency

USD

Distributions · last 12 months

Quarterly · 4 payments

Ex-datePaidAmount
Sep 15, 2026Sep 18, 2026$0.2789
Jun 15, 2026Jun 18, 2026$0.2848
Mar 17, 2026Mar 20, 2026$0.2845
Dec 16, 2025Dec 19, 2025$0.5853
Total, 12 months$1.43 a share

Dividend yield (TTM) 1.34% = $1.43 paid per share in the 12 months to Nov 20, 2026 ÷ the $107.05 price. Past distributions; future payments can differ.

Data last updated: Nov 10, 2026, 08:12 AM

Sectors

How the fund's assets are split across sectors.

2 sectors
  • 1Pharmaceuticals
    99.9%
  • 2Cash and/or Derivatives
    0.1%

Top sector

Pharmaceuticals

Top weight

99.9%

Top 3 weight

100.0%

Holdings

The securities the fund owns, by weight.

54 positions
1LLYELI LILLY
26.40%
2JNJJOHNSON & JOHNSON
21.92%
3ZTSZOETIS INC CLASS A
5.01%
4VTRSVIATRIS
4.90%
5RPRXROYALTY PHARMA PLC CLASS A
4.87%
6PFEPFIZER
4.34%
7MRKMERCK & CO INC
4.01%
8BMYBRISTOL MYERS SQUIBB
3.97%
9JAZZJAZZ PHARMACEUTICALS PLC
3.38%
10ELANELANCO ANIMAL HEALTH
2.80%
11CORTCORCEPT THERAPEUTICS
1.36%
12SUPNSUPERNUS
1.26%
13AXSMAXSOME THERAPEUTICS
1.25%
14LGNDLIGAND PHARMACEUTICALS
1.25%
15LQDALIQUIDIA
0.88%

Concentration

Total Holdings54
Top 10 Weight81.60%
Top HoldingLLY
Top Weight26.40%
1LLYELI LILLY
26.40%
2JNJJOHNSON & JOHNSON
21.92%
3ZTSZOETIS INC CLASS A
5.01%
4VTRSVIATRIS
4.90%
5RPRXROYALTY PHARMA PLC CLASS A
4.87%
6PFEPFIZER
4.34%
7MRKMERCK & CO INC
4.01%
8BMYBRISTOL MYERS SQUIBB
3.97%
9JAZZJAZZ PHARMACEUTICALS PLC
3.38%
10ELANELANCO ANIMAL HEALTH
2.80%
11CORTCORCEPT THERAPEUTICS
1.36%
12SUPNSUPERNUS
1.26%
13AXSMAXSOME THERAPEUTICS
1.25%
14LGNDLIGAND PHARMACEUTICALS
1.25%
15LQDALIQUIDIA
0.88%

Total Holdings

54

Top 10 Weight

81.60%

Top Holding

LLY

Top Weight

26.40%

1LLYELI LILLY
26.40%$447.78M
2JNJJOHNSON & JOHNSON
21.92%$371.71M
3ZTSZOETIS INC CLASS A
5.01%$84.99M
4VTRSVIATRIS
4.90%$83.05M
5RPRXROYALTY PHARMA PLC CLASS A
4.87%$82.52M
6PFEPFIZER
4.34%$73.54M
7MRKMERCK & CO INC
4.01%$68.00M
8BMYBRISTOL MYERS SQUIBB
3.97%$67.33M
9JAZZJAZZ PHARMACEUTICALS PLC
3.38%$57.35M
10ELANELANCO ANIMAL HEALTH
2.80%$47.56M
11CORTCORCEPT THERAPEUTICS
1.36%$22.99M
12SUPNSUPERNUS
1.26%$21.43M
13AXSMAXSOME THERAPEUTICS
1.25%$21.27M
14LGNDLIGAND PHARMACEUTICALS
1.25%$21.23M
15LQDALIQUIDIA
0.88%$14.94M

Total Holdings

54

Top 10 Weight

81.60%

Top Holding

LLY

Top Weight

26.40%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on20 funds
FundAsset classExpense ratioAssetsHoldings
IHEiShares US Pharmaceuticals ETFThis fundEquity0.37%$1.7B52

Comparable funds

  • BKMCBNY Mellon US Mid Cap Core Equity ETFEquity0.04%$657M403
  • DWMWisdomTree International Equity FundInternational Equity0.48%$651M1,339
  • IGEiShares North American Natural Resources ETFEquity0.37%$777M149
  • INDYiShares India 50 ETFEquity0.65%$596M50
  • IYMiShares US Basic Materials ETFEquity0.37%$1.2B40
  • IYZiShares U.S. Telecommunications ETFEquity0.37%$661M22
  • KSAiShares MSCI Saudi Arabia ETFEquity0.75%$557M109
  • PPHVanEck Pharmaceutical ETFEquity0.36%$1.1B26

More IShares ETFs

  • IBTGiShares iBonds Dec 2026 Term Treasury ETFFixed Income0.07%$1.8B7
  • IBTHiShares iBonds Dec 2027 Term Treasury ETFFixed Income0.07%$2.4B51
  • IBTIiShares iBonds Dec 2028 Term Treasury ETFFixed Income0.07%$2.3B48
  • IBTJiShares iBonds Dec 2029 Term Treasury ETFFixed Income0.07%$1.6B38
  • IBTKiShares iBonds Dec 2030 Term Treasury ETFFixed Income0.07%$1.2B26
  • IBTLiShares iBonds Dec 2031 Term Treasury ETFFixed Income0.07%$793M26
  • IBTMiShares iBonds Dec 2032 Term Treasury ETFFixed Income0.07%$639M15
  • IBTOiShares iBonds Dec 2033 Term Treasury ETFFixed Income0.07%$520M13
  • IBTPiShares iBonds Dec 2034 Term Treasury ETFFixed Income0.07%$375M4
  • IBTQiShares iBonds Dec 2035 Term Treasury ETFFixed Income0.07%$296M4
  • IBTRiShares iBonds Dec 2036 Term Treasury ETFFixed Income0.07%$111M4
  • ICFiShares Select U.S. REIT ETFReal Estate (Listed/REITs)0.32%$2.0B30
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.

News

Latest Market News

News

Latest Market News